Insulin Delivery Devices

  1. PHILIP FELIG, M.D.; and
  2. WILLIAM V. TAMBORLANE, M.D.
  1. Yale University School of Medicine;
    New Haven, Connecticut

    Excerpt

    Management of the insulin-dependent diabetic has long been characterized by debate between those advocating "tight" and those advocating "loose" control of blood glucose levels (1). Efforts to resolve this debate on the basis of retrospective or prospective evaluations of the effect of blood glucose control on the development of the long-term vascular and neurologic complications of diabetes have been inconclusive (2, 3). In recent years the focus has shifted from attempting to determine how diligent the patient, the physician, or both should be in applying conventional treatment to the development of newer forms of treatment such as islet cell transplantation

    This 100-word excerpt has been provided in the absence of an abstract.

    « Previous | Next Article »Table of Contents